Liraglutide Generics: Availability, Safety Considerations And What You Need To Know

With the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists, many may find themselves turning to generic ...

Dear Doctor: Heavy sensation in legs started at same time as new medication; what’s really to blame?

I’m an 83-year-old female who’s in good health. I don’t take any prescriptions, and I’m not overweight. I donate blood ...

Debilitating disability: struggles of families of children with chronic disabilities in Kerala

Explore the challenges faced by families in Kerala caring for children with chronic disabilities and the urgent need for ...
Morning Overview on MSN

Weight-loss drugs like Ozempic may quietly leave your muscles weaker, a new study warns

Millions of people taking semaglutide or tirzepatide for weight loss could be losing more than fat. A pharmacovigilance study ...

Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity

Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement ...

There’s a new way to treat sprains and strains. Hint: Ice is out.

Instead, newer research about the microscopic environment inside sore, injured joints and tissues suggests moving and ...

Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
News-Medical.Net

GLP-1 medications may improve long-term health for people with peripheral artery disease

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

What older adults need to know before taking a GLP-1 medication to lose weight

Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep ...

Trouble getting weight loss drugs covered by insurance? Here’s what to know

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

Medicare offers access to popular obesity drugs for $50 a month

Medicare is offering beneficiaries access to popular obesity drugs for a $50 monthly copay. Patients have to meet certain criteria to qualify. It's a temporary measure that runs through 2027.